The correlation between serum levels and placental tissue expression of PLGF and sFLT-1 and the FIGO grading of the placenta accreta spectrum disorders

References

• Committee R. No O. Obstetric care consensus no. 7: placenta accreta spectrum. Obstet Gynecol. 2018;132(6):E259–E275.
   PubMed Web of Science ®Google Scholar
• Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, et al. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand. 2021;100(8):1445–1453.
   PubMed Web of Science ®Google Scholar
• Bartels HC, Postle JD, Downey P, et al. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018;2018:1–11.
   Web of Science ®Google Scholar
• Tseng JJ, Chou MM, Hsieh YT, et al. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta. 2006;27(1):70–78.
   PubMed Web of Science ®Google Scholar
• Tseng JJ, Chou MM. Differential expression of growth-, angiogenesis- and invasion-related factors in the development of placenta accreta. Taiwan J Obstet Gynecol. 2006;45(2):100–106.
   PubMedGoogle Scholar
• Duzyj CM, Buhimschi IA, Laky CA, et al. Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study. BJOG. 2018;125(11):1441–1448.
   PubMed Web of Science ®Google Scholar
• Wehrum MJ, Buhimschi IA, Salafia C, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol. 2011;204(5):411.e1–411.e11.
   Google Scholar
• Alfirevic Z, Tang AW, Collins SL, et al. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. Ultrasound Obstet Gynecol. 2016;47(3):276–278.
   PubMed Web of Science ®Google Scholar
• Cali G, Forlani F, Timor-Trisch I, et al. Diagnostic accuracy of ultrasound in detecting the depth of invasion in women at risk of abnormally invasive placenta: a prospective longitudinal study. Acta Obstet Gynecol Scand. 2018;97(10):1219–1227.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–24.
   PubMed Web of Science ®Google Scholar
• Aryananda RA, Aditiawarman A, Gumilar KE, et al. Uterine conservative–resective surgery for selected placenta accreta spectrum cases: surgical–vascular control methods. Acta Obstet Gynecol Scand. 2022;101(6):639–648.
   PubMed Web of Science ®Google Scholar
• Nieto-Calvache AJ, Palacios-Jaraquemada JM, Aryananda RA, et al. How to identify patients who require aortic vascular control in placenta accreta spectrum disorders? Am J Obstet Gynecol MFM. 2022;4(1):100498.
   Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–683.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Hussein AM, Zosmer N, et al. A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta. Am J Obstet Gynecol. 2020;222(4):379.e1–379.e11.
   PubMed Web of Science ®Google Scholar
• Aryananda RA, Akbar A, Wardhana MP, et al. New three-dimensional/four-dimensional volume rendering imaging software for detecting the abnormally invasive placenta. J Clin Ultrasound. 2019;47(1):9–13.
   PubMed Web of Science ®Google Scholar
• Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2(9):656–663.
   PubMed Web of Science ®Google Scholar
• Hanna J, Goldman-Wohl D, Hamani Y, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med. 2006;12(9):1065–1074.
   PubMed Web of Science ®Google Scholar
• Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens. 2017;31(12):782–786.
   PubMed Web of Science ®Google Scholar
• Athanassiades A, Lala PK. Role of placenta growth factor (PlGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta. 1998;19(7):465–473.
   PubMed Web of Science ®Google Scholar
• Knuth A, Liu L, Nielsen H, et al. Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells. Am J Reprod Immunol. 2015;73(4):330–340.
   PubMed Web of Science ®Google Scholar
• Tayade C, Hilchie D, He H, et al. Genetic deletion of placenta growth factor in mice alters uterine NK cells. J Immunol. 2007;178(7):4267–4275.
   PubMed Web of Science ®Google Scholar
• McMahon K, Karumanchi SA, Stillman IE, et al. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. Am J Obstet Gynecol. 2014;210(1):68.e1-68–e4.
   Web of Science ®Google Scholar
• Biberoglu E, Kirbas A, Daglar K, et al. Serum angiogenic profile in abnormal placentation. J Matern Neonatal Med. 2016;29(19):3193–3197.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:1–15.
   Google Scholar
• Redman CWG, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009;30(SUPPL):38–42.
   Google Scholar
• Redman CWG, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213(4):S9.e1-S9–e4.
   PubMed Web of Science ®Google Scholar
• Ali H, Chandraharan E. Etiopathogenesis and risk factors for placental accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:4–12.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang L, Zhang F, et al. First trimester serum PIGF is associated with placenta accreta. Placenta. 2020;101:39–44.
   PubMed Web of Science ®Google Scholar
• Munoz J, Mulampurath S, Ramsey PS, et al. 409 Biomarker utility of placental growth factor (PlGF) for placenta previa and placenta accreta spectrum (PAS). Am J Obstet Gynecol. 2021;224(2):S263–S264.
   Web of Science ®Google Scholar